New injection shows promise for lung blood pressure disorder

NCT ID NCT06846554

Recruiting now Disease control Sponsor: Apollo Therapeutics Ltd Source: ClinicalTrials.gov ↗

First seen Nov 19, 2025 · Last updated May 24, 2026 · Updated 26 times

Summary

This study tests an experimental drug called APL-9796, given as injections under the skin, for people with pulmonary hypertension (high blood pressure in the lungs). The goal is to see if it is safe and tolerable, and whether it can improve blood flow and exercise ability. The trial involves 48 adults with different types of pulmonary hypertension, and participants must already have a heart monitor implant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Golden Jubilee Hospital
RECRUITING

Clydebank, United Kingdom
Hammersmith/Imperial Hospital
RECRUITING

London, London, W12 0HS, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••
Royal Brompton Hospital
RECRUITING

London, United Kingdom
Royal Papworth Hospital
RECRUITING

Cambridge, United Kingdom
Royal United Hospital Bath
RECRUITING

Bath, United Kingdom
Sheffield Teaching Hospitals
RECRUITING

Sheffield, United Kingdom

Conditions

Explore the condition pages connected to this study.

PULMONARY ARTERIAL HYPERTENSION